Kmc Speciality Hospitals India Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of KMC Speciality Hospitals (India) Ltd is ₹ 144.2 as of 23 Oct 15:30 . The P/E Ratio of KMC Speciality Hospitals (India) Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of KMC Speciality Hospitals (India) Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The ebitda of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The net profit of KMC Speciality Hospitals (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of KMC Speciality Hospitals (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About KMC Speciality Hospitals (India) Ltd

KMC Speciality Hospitals (India) Limited was originally incorporated as 'Advanced Medical Care Private Limited' on December 31, 1982 and was converted into a Public Limited Company on July 15, 1988.
The name of the Company was changed to 'Seahorse Hospitals Limited' on March 21, 1995 and to its current name 'KMC Speciality Hospitals (India) Limited' with effect from October 24, 2008. The Company is a part of the KMC Group of Hospitals based at Tiruchirappalli.
The Company is a super speciality hospital based in Trichy, belonging to the Kauvery Hospitals Group.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It provide quality healthcare to patients in key specialty areas such as Neurosurgery, Cardiovascular & thoracic surgery, Orthopedics, Plastic and Reconstructive Surgery, Gynecology, Neonatology and Nephrology (including renal transplants).

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of KMC Speciality Hospitals (India) Ltd and Syngene International Ltd

Which company has a larger market capitalization, KMC Speciality Hospitals (India) Ltd or Syngene International Ltd?

Market cap of KMC Speciality Hospitals (India) Ltd is 2,351 Cr while Market cap of Syngene International Ltd is 14,810 Cr

What are the key factors driving the stock performance of KMC Speciality Hospitals (India) Ltd and Syngene International Ltd?

The stock performance of KMC Speciality Hospitals (India) Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KMC Speciality Hospitals (India) Ltd and Syngene International Ltd?

As of October 25, 2026, the KMC Speciality Hospitals (India) Ltd stock price is INR ₹144.2. On the other hand, Syngene International Ltd stock price is INR ₹366.9.

How do dividend payouts of KMC Speciality Hospitals (India) Ltd and Syngene International Ltd compare?

To compare the dividend payouts of KMC Speciality Hospitals (India) Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.